DISPOSAL OF CONTROLLED SUBSTANCES



Similar documents
Title 16. Board of Pharmacy Proposed Text

Disposal of Pharmaceuticals, and their empty containers, in the Workplace

Statement of Mary L. Hendrickson,PharmD,MBA,RAC Director of Quality & Regulatory Affairs Capital Returns Inc., d/b/a Genco Pharmaceutical Services

A safe return and reuse protocol in the community pharmacy setting may include, but is not limited to, the following elements:

The Future of Pharmaceutical Waste Regulation. Elise Paeffgen Senior Associate Alston & Bird LLP

USE OF CONTROLLED SUBSTANCES AN OVERVIEW FOR RESEARCHERS

Drug Take-back Programs: Safe Disposal of Unused, Expired, or Unwanted Medications in North Carolina

Creating Secure Medicine Return Programs to Reduce Misuse of Medicines in King County & Washington State

Conflicts of Interest. Disposal of Pharmaceutical Waste: What a Technician. Who is interested in proper pharmaceutical waste disposal?

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS

Use of Controlled Substances in Research.

Safe Disposal of Unused Controlled Substances/

EPA s proposed hazardous waste pharmaceutical regulations

PHARMACEUTICAL WASTE UPDATE ON HANDLING AND DISPOSAL ASTSWMO MEETING August 11, 2011

UTCVM PHARMACY STANDARD OPERATING PROCEDURES

Report of the Task Force on Drug Return and Reuse Programs

Opioid overdose can occur when a patient misunderstands the directions

Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY

Drugs in Our Drinking Water

Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED

Reverse Distribution: An Intersection of Regulations Charlotte A. Smith, Senior Regulatory Advisor, PharmEcology Services, WM National Services, Inc.

247 CMR: BOARD OF REGISTRATION IN PHARMACY

SUPPLY CHAIN INTEGRITY AND SECURITY

UW School of Dentistry Comprehensive Medication Policy

Managing Pharmaceutical Waste at the LTC Provider Pharmacy

PREP WORKSHOP #11 Investigational Drug Disposal

American Society of Consultant Pharmacists Background

Investigational Drugs: Investigational Drugs and Biologics

ARKANSAS. Downloaded January 2011

NH Laws / Rules Regarding Limited Retail Drug Distributors

VERMONT2007. Drugs and Medical Supply Repository Study. Report to the Legislature on Act 139 Sec. 6 Report Relating to 8 V.S.A. 107 January 15, 2007

Safe Disposal of Medications and Sharps in the Home Setting. American Nurses Association & U.S. Food and Drug Administration

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Narcotic Treatment Programs

Biohazardous Waste and Sharps Disposal

STANDARD OPERATING PROCEDURE #401 CONTROLLED SUBSTANCES

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2006 Compliance

CHAPTER CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)

IHS National Prescription Drug Abuse Workgroup

Management of Pharmaceutical Wastes from Healthcare & Households. Rudy Vingris Product Manager PharmEcology Services Waste Management, Inc.

Administrative Policy

ARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:

Pharmaceutical Waste Initiatives: What Comes Next? ACPE # L05-P (0.1 CEU)

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)

RULE. The Administration of Medication in Louisiana Public Schools

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

Compliance Bulletin Solid Waste Medical Waste Treatment reviewed/revised February 2012

CONNECTICUT. Downloaded January D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11

IMP management at site. Dmitry Semenyuta

H 5230 S T A T E O F R H O D E I S L A N D

Hazardous Pharmaceutical Waste Management. Written by: Matthew Teeter, Environmental Compliance Consultant

Review of Maine Pharmacy Rules. An update of new rules adopted 12/11/2013

Track/Trace Solutions. for the Manufacturing Industry

Table of Contents. 2 P a g e

Eight Important Principles For Managing Prescription Medications In the Athletic Training Room

Pharmaceutical Waste Management Program St. Joseph Mercy Oakland. Pharmacy/Patient Care

Guidance for Industry

DEA REGISTRATION FEES FACT SHEET

Planning Issues for Hospital Pharmacies with Growing Outpatient Populations

Louisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists

Be it enacted by the People of the State of Illinois,

The Comprehensive Environmental Response,

BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY:

UCSD Controlled Substances Program Procedures

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Technical Information Paper No REFERENCES. See Appendix A for a list of reference information.

Pharmaceutical Waste Compliance Program

Transcription:

DISPOSAL OF CONTROLLED SUBSTANCES

WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association

Outline of Today s 2/2/2 PRESENTER Jan Harris Director, EHS Customer Compliance Sharps Compliance

Management of Unused Patient Dispensed Medications Merging the Sharps TakeAway with the Sharps MedSafe Program June 10, 2014

Bloodborne Pathogens Training Jan Harris, MPH Director, Environmental, Health & Safety Sharps Compliance www.sharpsinc.com jharris@sharpsinc.com 713-927-9956

In the U.S. Approximately 4 billion prescriptions are filled in the United States annually 35% of the dispensed medication goes unused Over 250 million pounds disposed of improperly

Unused Patient Medication Flushing unused patient medications down the toilet or sink can contaminate ground and drinking water Waste water treatment plants ill-equipped Improper disposal into the trash may lead to accidental ingestion and leaching from landfills Unintended ingestion by children or pets can also occur Prescription drug abuse is on the rise

The IPA Current Program

2005 Iowa Regulatory Environment In 2005 Iowa State Legislature passed House File 724 - Prescription Drug Donation Repository Program Authorizes medical facilities and pharmacies to redispense prescription drugs and supplies that would otherwise be destroyed.

2007 Federal Regulatory Environment February, 2007, FDA worked with the White House Office of National Drug Control Policy (ONDCP) to develop the first consumer guidance for proper disposal of prescription drugs: Follow any specific disposal instructions Do not flush prescription drugs unless instructed you to do so Kitty litter and trash Take advantage of community drug take-back programs Scratch out identifying information Do not share drugs When in doubt about proper disposal, talk to your pharmacist.

2009 State of Iowa and IPA How did the TakeAway Environmental Return System program come into being? Senate File 467 signed into law Pharmacy-based pharmaceutical collection and disposal pilot program. A $165,000 grant from the Iowa Department of Natural Resources was awarded to the Iowa Board of Pharmacy Implemented and administered by Iowa Pharmacy Association and Sharps Environmental Services, Inc.

TakeAway Environmental Return Systems

TakeAway Capabilities Unique operational agreement with USPS for envelopes Boxes shipped through UPS Tracked, validated and measurable results Process Handled by licensed law enforcement officials Securely stored (packaging is never opened) Weight and date stamped Witnessed and assured destruction No controls allowed

IPA Program

Secure & Responsible Drug Disposal Act of 2010 Controlled substances are 5 to 10% of medications collected, but are the larger problem Currently, long term care facilities (LTCF) can only dispose of controlled substances through Reverse Distributors or by destroying onsite Retail pharmacies cannot take back controlled substances from ultimate users Act allows for Take-back events (must include law enforcement) Mail-back programs (certain situations) Collection receptacles (certain locations)

2012 Proposed Change to 21 CFR Part 1300 21 CFR part 1300 regulations Can deliver unused portions of controlled substances to another entity for destruction without DEA registration if The person receiving controlled substance is authorized The drug is disposed of in accordance with regulations issued by the Attorney General. Finalized rule requirements from the DOJ/ DEA expected June, 2014

MedSafe and TakeAway Envelopes The Sharps Compliance Solutions MedSafe Onsite Collection Receptacle Mailback Envelope

MedSafe Pharmacy Collection Receptacle Collection Receptacle Inner Liner

Replaces the TakeAway boxes Collection Receptacle 14-gauge powder-coated steel construction Two locks secure main door One-way medicine drop with lock Removable, shipback Inner Liner Ships fully assembled with an Inner Liner, two padlocks and keys for the 3 locks Low maintenance Secures to floor or wall Signage for ultimate user instructions Collection instructions on inside of door Currently undergoing security testing to UL 291

Inner Liner Cost-effective pre-paid return via common carrier Traceable with unique barcode Includes all components to package for return Modeled after popular 20-Gallon TakeAway Environmental Return System Footprint similar (slightly larger) Meets pending DEA regulations for both non-controlled and controlled drug collection and removal for destruction

The Process MedSafe receptacle is placed visible to pharmacy counter Signage and marketing materials instruct ultimate users what to place into receptacle Customer places controls and non-controls into receptacle not taken by pharmacist Shipped UPS or picked up when full Never opened or sorted

TakeAway Envelopes and the New DEA Regulations Mailback envelopes will still be utilized A few adjustments will be made to current envelope Provided to ultimate users at the pharmacy counter to be taken home, filled and mailed

Same as TakeAway SharpsTracer Tracking Capabilities Secure, proprietary online data warehouse, unique for each client. Outbound inventory Returned inventory Date of return Condition of return Weight of return Current status of return (stored) Date of destruction Effectiveness check Number of scripts returned 7/24 access Availability of customized reporting

MedSafe - Marketing Materials 4-page full color brochure 4-page pdf brochure (email) PI Sheet Promotional slick

Resources Disposal of Controlled Substances Proposed Rule: www.gpo.gov/fdsys/pkg/fr-2012-12-21/pdf/2012-30699.pdf NACDS and NCPA comments on DEA regulations: http://drugtopics.modernmedicine.com/drugtopics/news/drug-topics/associations/nacds-ncpa-commentdea%e2%80%99s-proposal-safely-dispose-controlle Sharps: www.sharpsinc.com; 800-772-5657 25

MEDICAL CANNABIS ACROSS THE UNITED STATES Questions? Contact Laura Miller at lmiller@iarx.org or 515-270-0713